Axplora

Sector Healthcare
Location Frankfurt
Date acquired 2020
Transaction size Not disclosed

A leading manufacturer of active pharmaceutical ingredients


Axplora operates in a sector with attractive long-term market dynamics underpinned by an ageing population and increasing prevalence of chronic diseases. The global market for small molecule APIs is estimated to be worth over $70 billion annually. Given its scale and market leadership, the company is also well positioned to benefit from the longstanding and ongoing trend towards outsourcing, which benefits specialised manufacturers like Axplora as well as further consolidation in a fragmented market.

Bridgepoint initially invested in PharmaZell Group in 2020. The business merged with Novasep in 2022. To learn more about the company, click here.

Axplora partners with the world’s leading patient-centric pharmaceutical and biotechnology companies, delivering top quality active ingredients on time and at scale, to the highest industry standards. It was created by the merger of two companies sharing a track record of high quality products, reliability and a complementary set of differentiated technologies: PharmaZell Group (a manufacturer of generic active pharmaceutical ingredients (API) with the two brands PharmaZell and Farmabios) and Novasep (a development partner to innovator clients).

Axplora is dedicated to helping pharmaceutical companies make critical medicines better, faster, safely, reliably, and sustainably benefitting patients worldwide. Leveraging its combined expertise and manufacturing capabilities across nine industrial sites in Europe and India, and an R&D facility in the USA, Axplora offers CDMO solutions to innovators for their small molecule and biomolecular APIs, as well as products that address lifestyle-induced respiratory, inflammatory, and liver diseases. Headquartered in Raubling (near Munich, Germany), Axplora employs 2,400 people around the world. 

We use strictly necessary cookies to make our site work. Currently the analytics cookies which allow us to collect information about how visitors use our website and help us to improve it; is defaulted to ‘InActive’, if you wish to turn this on you can do so through the Cookie Settings. Please be aware that by blocking some types of cookies it may impact your experience of the site and the services we are able to offer. For more information about any of these cookies and our use of them, or to change your settings at any time, please see Cookie Settings and Cookies Policy.